Christine M Barbon
Affiliation: Harvard University
- Consecutive low doses of cyclophosphamide preferentially target Tregs and potentiate T cell responses induced by DNA PLG microparticle immunizationChristine M Barbon
Dana Farber Cancer Institute, Boston, MA, USA
Cell Immunol 262:150-61. 2010..Thus, we report the synergistic activity of pharmacologic T(reg) depletion with cyclophosphamide on quantitatively and qualitatively increasing T cell responses to a known human tumor-associated antigen...
- Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantationJeff K Davies
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
Cell Transplant 21:2047-61. 2012....